1. Home
  2. VERU vs INUV Comparison

VERU vs INUV Comparison

Compare VERU & INUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • INUV
  • Stock Information
  • Founded
  • VERU 1971
  • INUV N/A
  • Country
  • VERU United States
  • INUV United States
  • Employees
  • VERU N/A
  • INUV N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • INUV Advertising
  • Sector
  • VERU Health Care
  • INUV Consumer Discretionary
  • Exchange
  • VERU Nasdaq
  • INUV Nasdaq
  • Market Cap
  • VERU 54.6M
  • INUV 49.5M
  • IPO Year
  • VERU 1990
  • INUV N/A
  • Fundamental
  • Price
  • VERU $4.29
  • INUV $3.58
  • Analyst Decision
  • VERU Strong Buy
  • INUV Strong Buy
  • Analyst Count
  • VERU 3
  • INUV 3
  • Target Price
  • VERU $33.33
  • INUV $15.67
  • AVG Volume (30 Days)
  • VERU 158.4K
  • INUV 151.2K
  • Earning Date
  • VERU 08-12-2025
  • INUV 11-06-2025
  • Dividend Yield
  • VERU N/A
  • INUV N/A
  • EPS Growth
  • VERU N/A
  • INUV N/A
  • EPS
  • VERU N/A
  • INUV N/A
  • Revenue
  • VERU $16,886,419.00
  • INUV $97,940,442.00
  • Revenue This Year
  • VERU N/A
  • INUV $25.37
  • Revenue Next Year
  • VERU N/A
  • INUV $16.24
  • P/E Ratio
  • VERU N/A
  • INUV N/A
  • Revenue Growth
  • VERU 337.24
  • INUV 21.45
  • 52 Week Low
  • VERU $2.64
  • INUV $1.90
  • 52 Week High
  • VERU $14.20
  • INUV $7.90
  • Technical
  • Relative Strength Index (RSI)
  • VERU 74.55
  • INUV 48.24
  • Support Level
  • VERU $3.75
  • INUV $3.25
  • Resistance Level
  • VERU $3.99
  • INUV $3.67
  • Average True Range (ATR)
  • VERU 0.24
  • INUV 0.35
  • MACD
  • VERU -0.01
  • INUV -0.01
  • Stochastic Oscillator
  • VERU 94.34
  • INUV 28.74

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

Share on Social Networks: